peptides

You have access
Correlation of ⁶⁸Ga-RM2 PET with Post-Surgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru

Journal of Nuclear Medicine May 12, 2022, jnumed.122.263971; DOI: https://doi.org/10.2967/jnumed.122.263971
Open Access
⁶⁸Ga-DOTA-NT-20.3 Neurotensin receptor 1 positron emission tomography imaging as a surrogate for neuroendocrine differentiation of prostate cancer
Wen Yu Wu, Fei Yu, Peng Jun Zhang, Ting Bu, Jing Jing Fu, Shu Yue Ai, Qin Qin You, Liang Shi, Guo Qiang Shao, Feng Wang, Marina Hodolic and Hong Qian Guo

Journal of Nuclear Medicine February 17, 2022, jnumed.121.263132; DOI: https://doi.org/10.2967/jnumed.121.263132
Open Access
Synthesis and Preclinical Evaluation of ¹⁷⁷Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer
Alexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, Veronika Felber, Roswitha Beck, Francesco De Rose, Calogero D'Alessandria, Wolfgang Andreas Weber and Hans-Jürgen Wester

Journal of Nuclear Medicine January 27, 2022, jnumed.121.263371; DOI: https://doi.org/10.2967/jnumed.121.263371
Open Access
Substitution of L-Trp by α-methyl-L-Trp in ¹⁷⁷Lu-RM2 results in ¹⁷⁷Lu-AMTG, a high affinity GRPR ligand with improved in vivo stability
Thomas Guenther, Sandra Deiser, Veronika Felber, Roswitha Beck and Hans-Juergen Wester

Journal of Nuclear Medicine January 13, 2022, jnumed.121.263323; DOI: https://doi.org/10.2967/jnumed.121.263323
You have access
Affibody-mediated PNA-based pretargeted co-treatment improves survival of trastuzumab-treated mice bearing HER2-expressing xenografts
Maryam Oroujeni, Hanna Tano, Anzhelika Vorobyeva, Yongsheng Liu, Olga Vorontsova, Tianqi Xu, Kristina Westerlund, Anna Orlova, Vladimir Tolmachev and Amelie Eriksson Karlström

Journal of Nuclear Medicine October 28, 2021, jnumed.121.262123; DOI: https://doi.org/10.2967/jnumed.121.262123
Open Access
α_vβ₆-Targeted Molecular PET/CT Imaging of the Lungs After SARS-CoV-2 Infection
Cameron C. Foster, Ryan A. Davis, Sven H. Hausner and Julie L. Sutcliffe

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1717-1719; DOI: https://doi.org/10.2967/jnumed.120.255364
You have access
Biochemical Recurrence of Prostate Cancer: Initial Results with [¹⁸F]PSMA-1007 PET/CT
Frederik L. Giesel, Leon Will, Claudia Kesch, Martin Freitag, Christophe Kremer, Jonas Merkle, Oliver C. Neels, Jens Cardinale, Boris Hadaschik, Markus Hohenfellner, Klaus Kopka, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine April 1, 2018, 59 (4) 632-635; DOI: https://doi.org/10.2967/jnumed.117.196329
You have access
Current Concepts in ⁶⁸Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
Lisa Bodei, Valentina Ambrosini, Ken Herrmann and Irvin Modlin

Journal of Nuclear Medicine November 1, 2017, 58 (11) 1718-1726; DOI: https://doi.org/10.2967/jnumed.116.186361
You have access
The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
Martin Barrio, Johannes Czernin, Stefano Fanti, Valentina Ambrosini, Ina Binse, Lin Du, Matthias Eiber, Ken Herrmann and Wolfgang P. Fendler

Journal of Nuclear Medicine May 1, 2017, 58 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.116.185587
You have access
Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)₃-Conjugates in Important Organs
Matthias Eder, Thomas Löhr, Ulrike Bauder-Wüst, Markus Reber, Walter Mier, Martin Schäfer, Uwe Haberkorn and Michael Eisenhut

Journal of Nuclear Medicine August 1, 2013, 54 (8) 1327-1330; DOI: https://doi.org/10.2967/jnumed.112.114512

Main menu

User menu

Search

peptides